glp-1 receptor agonist ingredients supplier Market Size & Analysis, 2026-2033 GLP-1 Food Formulation: An Ingredient

Competing interests KS declares nothing to disclose

Who can benefit

Frequency unknown: Angioedema, back pain, cutaneous vasculitis, interstitial lung disease, joint disorders, myalgia, pancreatitis, renal impairment, StevensJohnson syndrome, hepatic function abnormalities

GH reports research grants from the Netherlands Organization for Scientific Research (vidi 016.156.445), CardioVascular Research Initiative, European Union and the Klinkerpad fonds, institutional research support from Aegerion, Amgen, AstraZeneca, Eli Lilly, Genzyme, Ionis, Kowa, Pfizer, Regeneron, Roche, Sanofi, and The Medicines Company

Our team of experts along with our broad portfolio makes it easy to: Screen for inhibitors/targets using our GIP and cell-based assays Obtain IC 50 or EC 50 determination or single point concentrations of compound series Perform follow-up studies Get questions answered or project guidance in a time-efficient manner Save time and resources by skipping assay or cell line development